Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100RO21
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥1.7bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax−¥3.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥3.1bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥572.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥595.7bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥428.9bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥143.7bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥144.0bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥54.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥8.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-25.52023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-25.52023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio25.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.2bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
—segment totalrevenue2023-04-01 → 2023-06-30¥80.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥80.8bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 864
ItemContextValueUnit
Comprehensive income IFRSCurrentYTDDuration12031000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration5948000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration11938000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration141000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration93000000JPY
Comprehensive income IFRSPrior1YTDDuration6089000000JPY
Comprehensive income IFRSCurrentYTDDuration12031000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember47065000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember44118000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember28353000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-568000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember412000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-92000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-7106000000JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember1182000000JPY
Other comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember55000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember90000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-7106000000JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember1182000000JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember55000000JPY
Comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember90000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember366000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-265000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-4709000000JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Dividends to non controlling interests ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass